Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

FDG Tumor Heterogeneity During Chemoradiation as a Predictor of Response to Concurrent Radiation Therapy and Chemotherapy in Patients With Cervical Cancer

NCT02317302 is registered in ClinicalTrials.gov with Washington University School of Medicine as lead sponsor.

NCT NCT02317302
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02317302 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
FDG Tumor Heterogeneity During Chemoradiation as a Predictor of Response to Concurrent Radiation Therapy and Chemotherapy in Patients With Cervical Cancer
Lead sponsor
Washington University School of Medicine
Phase
Phase 1
Overall status
Terminated
Start date
June 28, 2011
Completion date
June 2, 2020
Enrollment
48 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cervical cancer, uterine cervical cancer, uterine cervical neoplasms